Clinical Trial Update: Intramuscular Dose-Escalation Study With ETI-204 in Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 intramuscular dose-escalation study of ETI-204 in adult volunteers has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inhalational Anthrax

Drugs mentioned

• ETI-204

Snippet

Sponsor: Elusys Therapeutics | Conditions: Inhalational Anthrax | Phase 1 | Status: COMPLETED | Results posted: 2019-05-01